Skip to content

Spinal Cord stimulation for Intractable MONOneuropathy

Spinal Cord stimulation for Intractable MONOneuropathy - SCIMONO

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56537
Enrollment
15
Registered
2024-02-08
Start date
2024-05-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mononeuropathy

Interventions

Spinal cord stimulator implantation and 3 times blood collection

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Suffering from painful peripheral mononeuropathy in the distal extremities,  preferably post-traumatic or post-surgical, confirmed by EMG - Symptoms refractory to conventional medical management for at least 6 months  according to treating physician - 18 years or older - At least 5 out of 10 on the numerical rating scale for pain (average pain  intensity in week prior to assessment)

Exclusion criteria

Exclusion criteria: - Mononeuropathy located in the head or torso - Mononeuropathy by avulsion at the plexus brachialis - Life expectancy <1 year

Design outcomes

Primary

MeasureTime frame
The effect of 6 months of spinal cord stimulation in the test subjects on the 'IMMPACT guidelines' (perceived pain intensity, quality of life, physical and emotional functioning, and medication use)

Secondary

MeasureTime frame
- Effect of individually optimized spinal cord stimulation settings - Effect of 3 or 6 months of spinal cord stimulation on thermographic images, immunology, QST, and EMG. - Personal preference for spinal cord stimulation settings of the test subjects

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 9, 2026